INSPIRE IN THE NEWS

Nebula Genomics Inks Deal With EMD Serono To Help Enable Personal Genome Sequencing

Nebula Genomics Inks Deal With EMD Serono To Help Enable Personal Genome Sequencing

June 11, 2019
Brian Loew, CEO of Inspire: Accelerating medical progress through connected patients – Harlow On Healthcare

Brian Loew, CEO of Inspire: Accelerating medical progress through connected patients – Harlow On Healthcare

June 10, 2019
Adverse drug reactions detected on social media with natural language processing

Adverse drug reactions detected on social media with natural language processing

June 7, 2019
Hope: A Strategy for Managing Chronic Disease–Experts by Experience

Hope: A Strategy for Managing Chronic Disease–Experts by Experience

June 7, 2019
After my cancer diagnosis, some friends abandoned me. Then I did the same thing. Here’s why.

After my cancer diagnosis, some friends abandoned me. Then I did the same thing. Here’s why.

June 6, 2019
Breast cancer stole the life she had. So she started a new one

Breast cancer stole the life she had. So she started a new one

June 6, 2019
Search
Generic filters
Exact matches only
Filter by Custom Post Type
Content from
Content to
Nebula Genomics Inks Deal With EMD Serono To Help Enable Personal Genome Sequencing June 11, 2019 GenomeWeb
Nebula Genomics Inks Deal With EMD Serono To Help Enable Personal Genome Sequencing
Startup Nebula Genomics has partnered with EMD Serono, the biopharmaceutical business of Germany's Merck, for a whole-genome sequencing study of lung cancer. The project aims to test Nebula's platform, which enables individuals to obtain their own sequencing data and interact directly with genomics researchers for use of that data.
Read More
Brian Loew, CEO of Inspire: Accelerating medical progress through connected patients – Harlow On Healthcare June 10, 2019 Harlow On Healthcare
Brian Loew, CEO of Inspire: Accelerating medical progress through connected patients – Harlow On Healthcare
My guest for this episode of Harlow On Healthcare is Brian Loew, CEO of Inspire (@TeamInspire). Brian created Inspire in 2005 with the goal of accelerating clinical trial recruitment through the use of safe trusted online social networks organized by medical condition for patients and their caregivers.
Read More
Adverse drug reactions detected on social media with natural language processing June 7, 2019 AI in Healthcare
Adverse drug reactions detected on social media with natural language processing
Cancer patients undergoing chemotherapy often share word of their adverse reactions to the drugs in online health forums. Researchers at Stanford have used natural language processing to mine these posts, accurately flagging detrimental side effects well before clinical journals advise caution.
Read More
Hope: A Strategy for Managing Chronic Disease–Experts by Experience June 7, 2019 Mayo Clinic
Hope: A Strategy for Managing Chronic Disease–Experts by Experience
Time is one of the most priceless gifts we all have, but which can be robbed in an instant from those of us with chronic illness and disease.
Read More
After my cancer diagnosis, some friends abandoned me. Then I did the same thing. Here’s why. June 6, 2019 The Philadelphia Inquirer
After my cancer diagnosis, some friends abandoned me. Then I did the same thing. Here’s why.
I was fortunate to have an incredible social support system when I was diagnosed with Stage IV colon cancer at age 35. Still, I struggled when some of the people I thought I could count on virtually evaporated from my life.
Read More
Breast cancer stole the life she had. So she started a new one June 6, 2019 Philadelphia Inquirer
Breast cancer stole the life she had. So she started a new one
Cancer stole the future as I had imagined it and yet I was the one who had to do the time. My friends and family showed up for visitation. My aunt sat beside me while chemo pumped through my veins.
Read More
Three randomized controlled trials evaluating the impact of “spin” in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit June 5, 2019 BMC Medicine
Three randomized controlled trials evaluating the impact of “spin” in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit
News stories represent an important source of information. We aimed to evaluate the impact of “spin” (i.e., misrepresentation of study results) in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit.
Read More
Early Detection of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Detection June 3, 2019 JMIR Publications
Early Detection of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Detection
Adverse drug reactions (ADRs) occur in nearly all patients on chemotherapy, causing morbidity and therapy disruptions. Detection of such ADRs is limited in clinical trials, which are underpowered to detect rare events.
Read More
Patient Insights: Severe psoriasis & eczema May 20, 2019 Pharmaphorum
Patient Insights: Severe psoriasis & eczema
Howard Chang has lived with severe psoriasis and atopic dermatitis for almost 40 years since childhood. Now a prolific blogger, he hopes to help other people feel less alone and build more awareness of these challenging conditions.
Read More
Accidental Path to a Cancer Cure – Experts by Experience May 17, 2019 Mayo Clinic
Accidental Path to a Cancer Cure – Experts by Experience
Incontinence was a major problem for me 15 years ago. Guiding my cousins around the National Mall in Washington D.C. one day, I had to find a restroom for urinary relief several times.
Read More